Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Advanced Type 2 Diabetes

NCT05975528 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT05975528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05975528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Advanced Type 2 Diabetes
Lead sponsor
Yonsei University
Phase
Phase 4
Overall status
Unknown status
Start date
June 1, 2023
Completion date
December 31, 2025
Enrollment
92 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cellular senescence, diabetes mellitus, sodium-glucose transporter 2 inhibitors